# Pacifico Biolabs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pacifico-biolabs

- Industry: Biotechnology
- Headquarters: Berlin, Germany
- Website: www.pacifico.bio/
- Total disclosed funding: $8.1M
- Latest round: Series A (Apr 1, 2026)
- Investors on record: 5

## About

Based in Berlin, Germany, and founded in 2022, Pacifico Biolabs, a biotechnology company, utilizes a fermentation process that involves cultivating various microorganisms, including mycelium, to enhance nutrition, flavor, and texture. Additionally, they repurpose side streams from other food productions to minimize food waste. The company was co-founded by Zac Austin (CEO) and Washington Logroño. In May 2026, Pacifico Biolabs GmbH raised EUR 7 million in series A funding from Stray Dog Capital, Technologiegruenderfonds Sachsen, Sprout & About Ventures, and Simon Capital, FoodLabs and others. The company will use the May 2026 funding to expand its production capacity, grow its team, and support commercial launch and market expansion across Europe.

## Funding rounds

- Series A, Apr 1, 2026, $8.1M — CFH Management, Foodlabs, Stray Dog Capital, Simon Capital, Sprout & About Ventures

## Investors

- CFH Management (https://capitalatlas.ai/funds/cfh-management) — Series A
- Foodlabs (https://capitalatlas.ai/funds/foodlabs) — Series A
- Stray Dog Capital (https://capitalatlas.ai/funds/stray-dog-capital) — Series A
- Simon Capital (https://capitalatlas.ai/funds/simon-capital) — Series A
- Sprout & About Ventures — Series A